The SXT element is a Vibrio cholerae-derived ICE (integrating and conjugative element), which has also been referred to as a conjugative transposon (1) or a constin (2). ICEs excise from the chromosomes of their hosts, transfer to a new host through conjugation, and then integrate into the chromosome again. SXT element was originally isolated in 1993 from a V. cholerae O139 clinical isolate (SXT MO10 ) (1). The ≈100-kbp SXT element confers resistance to sulfamethoxazole, trimethoprim, chloramphenicol, and streptomycin (1). Since 1994, V. cholerae isolates from Bangladesh, India, and Mozambique have also contained the SXT element (2-4). In SXT MO10 , resistance genes are embedded near the 5′ end, in a ≈17.2-kbp composite transposon-like element that interrupts the SXT-encoded rumAB operon. In contrast, in El Tor O1 V. cholerae strains isolated in India and Bangladesh, the resistance genes are located in SXT ET , which is closely related but not identical to SXT MO10 (2). Comparison of 2 related ICEs, SXT of V. cholerae and R391 of Providencia rettgeri (5), showed that the conserved backbone apparently contains 3 hot spots for insertions of additional DNA sequences: the first between sO43 and traL, the second
between trA and sO54, and the third between sO73 and traF. R391 contains an intact rumAB operon and a transposon-associated kanamycin resistance gene located ≈3.5 kbp from the rumAB operon (6) . Mobile genetic elements such as SXT have a crucial role in spreading antimicrobial drug resistance genes among microbial populations, and our understanding of these genetic elements would help to control the emergence of antimicrobial drug resistance.
We have been monitoring the drug sensitivity pattern in the Lao People's Democratic Republic (Laos) since 1993, and we have found that V. cholerae O1 strains isolated after 1997 were resistant to tetracycline, sulfamethoxazole, trimethoprim, chloramphenicol, and streptomycin (7) . Analysis of the genetic determinants encoding antimicrobial drug resistance showed an SXT element (SXT LAOS ), which is different from the previously reported SXTs (8) . SXT LAOS contains 2 novel open reading frames (ORFs) in the third hot spot (between sO73 and traF). SXT ET contains a class 9 integron in hot spot sO73-traF that harbors dfrA1 as a gene cassette (2) . In SXT MO10 , the gene encoding trimethoprim resistance (dfr18) is encoded in the ≈17.2-kbp composite transposon-like element that interrupts the SXT-encoded rumAB operon. SXT LAOS does not encode dfr18 or dfrA1, and the gene encoding trimethoprim resistance has not been identified. In this study, we analyzed hot spot sO43-traL and hot spot traA-sO54 to better characterize SXT LAOS .
Two sets of primers were designed to amplify the hot spot regions. Primer HS1-F, which anneals to sO43, was 5′ GGC TAT TCC ACC GGT GGT G 3′; primer HS1-R, which anneals to traL, was 5′ TGC CGA TCA CTA GCC CCA AC 3′; primer HS2-F, which anneals to traA, was 5′ ATG GGT CTC TAC AAT ACG CC 3′; and primer HS2-R, which anneals to sO54, was 5′ GGA GAC AGC GCA AGC GCC AG 3′. Polymerase chain reaction (PCR) amplifications on genomic DNA extracted from the V. cholerae O1 strain isolated in Laos (strain 00LA1) with primers HS1-F and HS1-R yielded an amplicon of ≈1100 bp, which is slightly different from the amplicon obtained with DNA extracted from V. cholerae O139, strain MO10 (≈1,000 bp). PCR amplification using primers HS2-F and HS2-R gave amplicons of similar size (≈2,200 bp) for both strains. The ≈1,000-bp and ≈2,200-bp PCR products from strain 00LA1 were cloned independently into the pCR 2.1 vector and tested to determine if recombinant plasmids confer trimethoprim resistance after transformation to Escherichia coli. No trimethoprimresistant colonies were observed after transformation. The nucleotide sequences of the inserted fragments were analyzed. The region between sO43 and traL showed 97% identity to the corresponding region of P. rettgeri R391 (accession no. AY090559), which encodes 2 hypothetical proteins (ORF 37 and ORF 38). The region between traA and sO54 showed 97% identity to the corresponding region of SXT MO10 (accession no. AY055428). Since the gene encoding trimethoprim resistance was not located in any of the hot spot regions proposed by Beaber et al. (5), we also analyzed the region between sO26 and sO27, which in R391 contains the kanamycin resistance gene. Primers sO26-F (5′ GAG CAA TGG GCG AGA GTT CC) and s027-R (5′ TCA GCG ACA ACC GGA GAA TG) gave an amplicon of 409 bp for SXT MO10 , as expected, while no PCR product was obtained for SXT LAOS . This result suggested that the region between sO26 and sO27 in SXT LAOS is also different from SXT MO10 .
V. cholerae O139 has not been isolated in Laos, and the SXT element was not likely transmitted from a V. cholerae O139 strain to a V. cholerae O1 strain. Since SXT LAOS has a hot spot that is identical to R391, we show evidence for a possible independent emerging of SXT LAOS . Further analysis is needed to understand the evolution and relationship between different ICEs and the emergence of new variants.
In a previous study (8), we confirmed experimentally that trimethoprim resistance was also transferred by conjugation, and we hypothesized that the responsible gene is located within SXT LAOS . However, the gene was not found in any of the proposed hot spot regions. The possibility that the trimethoprim resistance determinant is located on the chromosome outside the SXT element and cotransfers with the SXT in an Hfr-like manner cannot be ruled out (9) . Therefore, additional hot spot regions may exist in SXT elements for insertion of DNA; otherwise the trimethoprim resistance gene is not encoded within SXT LAOS .
The nucleotide sequence data reported in this study will appear in the DDBJ/EMBL/GenBank nucleotide sequence databases with the accession numbers AB185252 for the hot spot sO43-traL and AB186353 for the hot spot traA-sO54.
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Modeling the Impact of Pandemic Influenza on Pacific Islands
To the Editor: Many Pacific Island countries and areas have been severely impacted in influenza pandemics. The 1918 pandemic killed substantial proportions of the total population: Fiji ≈5.2%, Tonga ≈4.2% to 8.4%, Guam ≈4.5%, Tahiti ≈10%, and Western Samoa ≈19% to 22% (1,2). Thirty-one influenza pandemics have occurred since the first pandemic in 1580 (3); another one is likely, if not inevitable (4) . The potential use of influenza as a bioweapon is an additional concern (5).
The scale of an influenza pandemic may be projected on the basis of the available historical data that have been built into a computer model, e.g., FluAid (6) . FluAid uses a deterministic model to estimate the impact range of an influenza pandemic in its first wave. Given the lack of accessible data for specific Pacific Island countries and areas, the default values used in FluAid were used for the proportion of the population in the high-risk category for each age group, for the death rates, hospitalizations, and illness requiring medical consultations. Country-specific population data were obtained from the Secretariat of the Pacific Community, and hospital bed data were obtained from the World Health Organization (WHO) (7, 8) . The FluAid model was supplemented by a model of an 8-week pandemic wave and modeling of hospital bed capacity. Further methodologic details are provided in the online Appendix (available from htttp:// www.cdc.gov/ncidod/EID/vol11no02 /04-0951_app.htm).
The results indicate that at incidence rates of 15% and 35%, pandemic influenza would cause 650 and 1,530 deaths, respectively, giving crude death rates of 22 to 52 per 100,000 (see the Table in the online Appendix). Most deaths (83%) would occur in the high-risk group, 60% of whom would be 19-64 years of age, and 22% would be ≥65 years of age. Additionally, 3,540 to 8,250 persons would be hospitalized, most of whom (78%) would not have high-risk conditions. Also, 241,000 to 563,000 medical consultations would occur. Most (87%) consultations would be for patients without high-risk conditions (50% birth-18 years of age and 46% 19-64 years of age).
In the peak week of the pandemic (week 4), from 15% to 34% of all hospital beds would be required for patients with influenza (Table) . The upper end of impact on hospital beds at >40% would occur for Guam,
